235
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Ocular Findings in Subacute Sclerosing Panencephalitis

, MD, , MD, , MD, , MD, Assoc. Prof. & , MD, Assoc. Prof.
Pages 135-138 | Received 26 Aug 2010, Accepted 25 Oct 2010, Published online: 23 Mar 2011
 

Abstract

Purpose: The aim of this study was to evaluate the ocular manifestations of subacute sclerosing panencephalitis (SSPE) and to investigate possible risk factors in a relatively large series of patients.

Methods: In this prospective study, patients who were diagnosed with SSPE and had undergone ophthalmic examination were included.

Results: Of the 59 patients with SSPE, 25 (42.4%) had ocular findings. Ocular involvement was bilateral in 22 (88%) patients. The most characteristic fundus findings in our patients were chorioretinitis. No significant difference was found between the two groups in terms of age, gender, clinical stage, and ocular findings.

Conclusions: Although ophthalmological findings do not constitute a part of the diagnostic criteria, and the correlation between the clinical stage of SSPE and the ocular findings is unclear, patients with SSPE should be screened and followed up for ocular involvement.

ACKNOWLEDGMENTS

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.